[Disseminated renal adenocarcinoma. Developmental study].

Area of Science:

• Oncology
• Nephrology
• Medical research

Context:

• Study focuses on disseminated renal adenocarcinoma, a severe form of kidney cancer.
• Investigates a cohort of 57 patients with varying symptom-to-diagnosis intervals.
• Highlights frequent metastasis to lungs and bone in affected patients.

Purpose:

• To evaluate and compare survival outcomes for disseminated renal adenocarcinoma patients.
• Assesses the efficacy of nephrectomy versus drug therapy alone in extending patient survival.
• Examines the impact of surgical intervention (nephrectomy, lymphadenectomy) on overall survival.

Summary:

• A cohort of 57 disseminated renal adenocarcinoma patients was analyzed.
• Patients were divided into two groups: those undergoing nephrectomy (with or without lymphadenectomy) and those receiving drug therapy.
• No statistically significant difference in survival was observed between the two treatment groups.

Impact:

• Findings suggest that nephrectomy may not significantly improve survival compared to drug therapy alone for advanced renal adenocarcinoma.
• Provides data for clinical decision-making regarding treatment strategies for disseminated kidney cancer.
• Contributes to understanding the prognostic factors and treatment effectiveness in advanced renal adenocarcinoma.